[Federal Register Volume 85, Number 224 (Thursday, November 19, 2020)]
[Notices]
[Pages 73712-73713]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-25658]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[Docket No. CDC-2020-0117]


Advisory Committee on Immunization Practices (ACIP)

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice of meeting and request for comment.

-----------------------------------------------------------------------

SUMMARY: In accordance with the Federal Advisory Committee Act, the 
Centers for Disease Control and Prevention (CDC), announces the 
following meeting of the Advisory Committee on Immunization Practices 
(ACIP). This meeting is open to the public. Time will be available for 
public comment. The meeting will be webcast live via the World Wide 
Web.

DATES: The meeting will be held on November 23, 2020 from 12:00 p.m. to 
5:00 p.m., EST (times subject to change).
    Written comments must be received on or before November 23, 2020.

ADDRESSES: For more information on ACIP please visit the ACIP website: 
http://www.cdc.gov/vaccines/acip/index.html.
    You may submit comments, identified by Docket No. CDC-2020-0117 by 
any of the following methods:
     Federal eRulemaking Portal: https://www.regulations.gov. 
Follow the instructions for submitting comments.
     Mail: Docket No. CDC-2020-0117, c/o Attn: November 23, 
2020 ACIP Meeting, Centers for Disease Control and Prevention, 1600 
Clifton Road NE, MS H24-8, Atlanta, GA 30329-4027.
    Instructions: All submissions received must include the Agency name 
and Docket Number. All relevant comments received in conformance with 
the https://www.regulations.gov suitability policy will be posted 
without change to https://www.regulations.gov, including any personal 
information provided. For access to the docket to read background 
documents or comments received, go to https://www.regulations.gov.
    Written public comments submitted by 24 hours prior to the ACIP 
meeting will be provided to ACIP members before the meeting.

FOR FURTHER INFORMATION CONTACT: Stephanie Thomas, ACIP Committee 
Management Specialist, Centers for Disease Control and Prevention, 
National Center for Immunization and Respiratory Diseases, 1600 Clifton 
Road, NE, MS-H24-8, Atlanta, GA 30329-4027; Telephone: 404-639-8367; 
Email: [email protected].

SUPPLEMENTARY INFORMATION: 
    Purpose: The committee is charged with advising the Director, CDC, 
on the use of immunizing agents. In addition, under 42 U.S.C. 1396s, 
the committee is mandated to establish and periodically review and, as 
appropriate, revise the list of vaccines for administration to vaccine-
eligible children through the Vaccines for Children (VFC) program, 
along with schedules regarding dosing interval, dosage, and 
contraindications to administration of vaccines. Further, under 
provisions of the Affordable Care Act, section 2713 of the Public 
Health Service Act, immunization recommendations of the ACIP that have 
been approved by the Director of the Centers for Disease Control and 
Prevention and appear on CDC immunization schedules must be covered by 
applicable health plans.
    Matters To Be Considered: The agenda will include discussions on 
COVID-19 vaccines. No recommendation vote is scheduled for COVID-19 
vaccines. Agenda items are subject to change as priorities dictate. For 
more information on the meeting agenda visit https://www.cdc.gov/vaccines/acip/meetings/meetings-info.html.
    Meeting Information: The meeting will be webcast live via the World 
Wide Web; for more information on ACIP please visit the ACIP website: 
http://www.cdc.gov/vaccines/acip/index.html.

Public Participation

    Interested persons or organizations are invited to participate by 
submitting written views, recommendations, and data. Please note that 
comments received, including attachments and other supporting materials 
are part of the public record and are subject to

[[Page 73713]]

public disclosure. Do not include any information in your comment or 
supporting materials that you consider confidential or inappropriate 
for public disclosure. If you include your name, contact information, 
or other information that identifies you in the body of your comments, 
that information will be on public display. CDC will review all 
submissions and may choose to redact, or withhold, submissions 
containing private or proprietary information such as Social Security 
numbers, medical information, inappropriate language, or duplicate/near 
duplicate examples of a mass-mail campaign. CDC will carefully consider 
all comments submitted into the docket. CDC does not accept comment by 
email.
    Oral Public Comment: This meeting will include time for members of 
the public to make an oral comment. Oral public comment will occur 
before any scheduled votes including all votes relevant to the ACIP's 
Affordable Care Act and Vaccines for Children Program roles. Priority 
will be given to individuals who submit a request to make an oral 
public comment before the meeting according to the procedures below.
    Procedure for Oral Public Comment: All persons interested in making 
an oral public comment at the November ACIP meeting must submit a 
request at http://www.cdc.gov/vaccines/acip/meetings/ no later than 
11:59 p.m., EST, November 19, 2020 according to the instructions 
provided.
    If the number of persons requesting to speak is greater than can be 
reasonably accommodated during the scheduled time, CDC will conduct a 
lottery to determine the speakers for the scheduled public comment 
session. CDC staff will notify individuals regarding their request to 
speak by email by November 20, 2020. To accommodate the significant 
interest in participation in the oral public comment session of ACIP 
meetings, each speaker will be limited to 3 minutes, and each speaker 
may only speak once per meeting.
    Written Public Comment: Written comments must be received on or 
before November 23, 2020.
    In accordance with 41 CFR 102-3.150(b), less than 15 calendar days' 
notice is being given for this meeting due to the exceptional 
circumstances of the COVID-19 pandemic and rapidly evolving COVID-19 
vaccine development and regulatory processes. A notice of this ACIP 
meeting has also been posted on the ACIP website at: http://www.cdc.gov/vaccines/acip/index.html.
    In the interest of promoting openness and transparency, we are 
publishing a late notice in the Federal Register to inform the public.
    The Director, Strategic Business Initiatives Unit, Office of the 
Chief Operating Officer, Centers for Disease Control and Prevention, 
has been delegated the authority to sign Federal Register notices 
pertaining to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention and 
the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2020-25658 Filed 11-17-20; 4:15 pm]
BILLING CODE 4163-18-P